Global Cancer Vaccines Market Size & Outlook, 2023-2030
Global cancer vaccines market, 2018-2030 (US$M)
Related Markets
Global cancer vaccines market highlights
- The global cancer vaccines market generated a revenue of USD 8,452.7 million in 2023 and is expected to reach USD 14,746.4 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.3% by 2030.
- In terms of segment, preventive cancer vaccines accounted for a revenue of USD 7,974.5 million in 2023.
- Other Types is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 8,452.7 million |
| Market revenue in 2030 | USD 14,746.4 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Preventive cancer vaccines |
| Fastest growing segment | Other Types |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Preventive Cancer Vaccines, Therapeutic Cancer Vaccines, Other Types |
Other key industry trends
- In terms of revenue, the North America accounted for 34.0% of the global cancer vaccines market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 130.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Vaccines Market Scope
Cancer Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global cancer vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer vaccines market will help companies and investors design strategic landscapes.
Preventive cancer vaccines was the largest segment with a revenue share of 94.34% in 2023. Horizon Databook has segmented the Global cancer vaccines market based on preventive cancer vaccines, therapeutic cancer vaccines, other types covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Cancer Vaccines Vaccine Type Outlook (Revenue, USD Million, 2018-2030)
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
- Other Types
- Global Cancer Vaccines Indication Type Outlook (Revenue, USD Million, 2018-2030)
- Prostate Cancer
- Bladder Cancer
- Melanoma
- Cervical
- Other Indications
- Global Cancer Vaccines Technology Type Outlook (Revenue, USD Million, 2018-2030)
- Recombinant Cancer Vaccines
- Viral Vector and DNA Cancer Vaccines
- Other Technologies
Reasons to subscribe to Global cancer vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global cancer vaccines market databook
-
Our clientele includes a mix of cancer vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global cancer vaccines market , including forecasts for subscribers. This global databook contains high-level insights into Global cancer vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global cancer vaccines market size, by regions, 2018-2030 (US$M)
Top 10 countries: Cancer vaccines market size, 2023 (US$M)
Global cancer vaccines market share, by vaccine type, 2023 & 2030 (%, US$M)
Cancer vaccines market: Opportunity assessment by country
Global cancer vaccines market, by region, 2023 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
